Cognition Therapeutics, Inc.CGTXNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank20
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-77.76%
Near historical average
Percentile
P20
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-81.86%
Historical baseline
PeriodValue
2024-77.76%
202313.57%
2022-410.41%
2021-5.77%
2020-10.81%
20190.00%